NAPROXEN / 550 mg Tablet & 750 mg CR Tablet

NAPROXEN / 550 mg Tablet & 750 mg CR Tablet
Product Description

ABDI IBRAHIM ILAC SAN. VE TIC. A.S.

  • TR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service
Distributor/Import Export
Licensee
Manufacturer/Innovator
Wholesale/Retail

ABDI IBRAHIM ILAC SAN. VE TIC. A.S.

  • TR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service
Distributor/Import Export
Licensee
Manufacturer/Innovator
Wholesale/Retail

More Products from ABDI IBRAHIM ILAC SAN. VE TIC. A.S. (99)

ABDI IBRAHIM ILAC SAN. VE TIC. A.S. resources (2)

  • News Abdi İbrahim Receives 'Equal Opportunity Model' Certificate for Women's Employment

    Abdi İbrahim has been awarded the 'Equal Opportunity Model' (FEM) certificate, developed by KAGIDER with the technical support of the World Bank, to promote gender equality in business life and enhance women's productivity. Deniz Daver, President of Human and Culture Group, expressed their happiness in receiving this certificate, stating, “This certificate, which acknowledges companies' sensitive approaches to gender equality and women's empowerment in employment, is an important indicator reflecting Abdi İbrahim's vision of inclusiveness. We see FEM certificate as a reward for our determined and continuous efforts in this field.
  • Brochure HEALING THE LIVES, HEALING THE FUTURE THAT’S WHAT WE DO.

    Turkish pharmaceutical industry leader Abdi Ibrahim s journey began in 1912.In addition to its partnerships with more than 30 licensing firms across the globe, Abdi Ibrahim develops its own products with 250 brands and 500 products.Abdi Ibrahim has subsidiaries operating in 17 countries outside Turkey, exports to more than 70 countries from the European Union to Canada, North Africa to Asia and generates the highest employment rate in the Turkish pharmaceutical industry with 5500 qualified employees.